Cargando…
Cost-effectiveness of Prophylactic Zika Virus Vaccine in the Americas
Zika virus remains a major public health concern because of its association with microcephaly and other neurologic disorders in newborns. A prophylactic vaccine has the potential to reduce disease incidence and eliminate birth defects resulting from prenatal Zika virus infection in future outbreaks....
Autores principales: | Shoukat, Affan, Vilches, Thomas, Moghadas, Seyed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874261/ https://www.ncbi.nlm.nih.gov/pubmed/31742512 http://dx.doi.org/10.3201/eid2512.181324 |
Ejemplares similares
-
Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia
por: Shoukat, Affan, et al.
Publicado: (2018) -
Projecting influenza vaccine effectiveness: A simulation study
por: Vilches, Thomas N., et al.
Publicado: (2020) -
Dynamics of HSV-2 infection with a therapeutic vaccine
por: Venturino, Ezio, et al.
Publicado: (2020) -
Estimating COVID-19 Infections, Hospitalizations, and Deaths Following the US Vaccination Campaigns During the Pandemic
por: Vilches, Thomas N., et al.
Publicado: (2022) -
Asymptomatic Transmission and the Dynamics of Zika Infection
por: Moghadas, Seyed M., et al.
Publicado: (2017)